# Clinical Trial of Simvastatin to Treat Generalized Vitiligo

> **NCT01517893** · PHASE2 · COMPLETED · sponsor: **John Harris** · enrollment: 15 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01517893
- **Lead sponsor:** John Harris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517893, "Clinical Trial of Simvastatin to Treat Generalized Vitiligo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01517893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*